TechnicianClinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, AustriaVienna, Vorarlberg, Austria
OC 46.5 - Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
Monday, June 26, 202315:45 – 16:00 ET
